RxDoctor Payments Data

Panagiotis Valilis

Hematology & Oncology · El Paso, TXNPI 1033158480

Payments from drug & device makers

$132,006in general payments, 2019–2025

Across 47 payments — averaging $2808.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$124K
  • Novocure Inc.$6K
  • Incyte Corporation$534
  • AstraZeneca$522
  • Rigel Pharmaceuticals, Inc.$250
  • Genentech USA, Inc.$190
  • plus $822 from 11 others

What the payments were for

  • Speaking & faculty fees$50021%
  • Food & beverage$1,45360%
  • Education$46619%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$132,006 in reported general payments places this provider in the 70th percentile of 838 hematology & oncology providers in Texas.

See all hematology & oncology providers in Texas

Other hematology & oncology in El Paso

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →